Primary |
Colitis Ulcerative |
30.8% |
Systemic Lupus Erythematosus |
15.4% |
Adrenal Insufficiency |
7.7% |
Antipyresis |
7.7% |
Depression |
7.7% |
Drug Eruption |
7.7% |
Gastrointestinal Disorder Therapy |
7.7% |
Polymyositis |
7.7% |
Staphylococcal Sepsis |
7.7% |
|
Eosinophilic Myocarditis |
33.3% |
Osteoarthritis |
33.3% |
Serotonin Syndrome |
33.3% |
|
Secondary |
Rheumatoid Arthritis |
32.9% |
Colitis Ulcerative |
9.1% |
Prophylaxis |
7.2% |
Drug Use For Unknown Indication |
5.0% |
Renal Transplant |
4.9% |
Hypertension |
4.9% |
Product Used For Unknown Indication |
4.7% |
Asthma |
4.1% |
Castleman's Disease |
4.0% |
Chronic Hepatitis C |
3.7% |
Interstitial Lung Disease |
2.9% |
Osteoporosis |
2.7% |
Crohn's Disease |
2.4% |
Juvenile Arthritis |
1.8% |
Gastritis |
1.8% |
Diabetes Mellitus |
1.7% |
Infection Prophylaxis |
1.7% |
Pustular Psoriasis |
1.6% |
Idiopathic Thrombocytopenic Purpura |
1.5% |
Insomnia |
1.4% |
|
Vomiting |
12.8% |
Pneumocystis Jiroveci Pneumonia |
11.3% |
Sepsis |
11.0% |
Pneumonia |
6.5% |
White Blood Cell Count Decreased |
5.8% |
White Blood Cell Count Increased |
5.5% |
Renal Impairment |
4.9% |
Pulmonary Tuberculosis |
4.5% |
Rash |
3.9% |
Diabetes Mellitus |
3.8% |
Toxic Epidermal Necrolysis |
3.7% |
Spinal Compression Fracture |
3.5% |
Gastroenteritis |
3.3% |
Interstitial Lung Disease |
3.2% |
Pneumocystis Jirovecii Pneumonia |
3.2% |
Stomatitis |
2.9% |
Bronchopulmonary Aspergillosis |
2.7% |
Pyrexia |
2.6% |
Upper Respiratory Tract Inflammation |
2.6% |
Erythema Multiforme |
2.4% |
|
Concomitant |
Rheumatoid Arthritis |
29.5% |
Prophylaxis |
14.4% |
Product Used For Unknown Indication |
9.5% |
Colitis Ulcerative |
5.5% |
Drug Use For Unknown Indication |
5.5% |
Hypertension |
5.4% |
Osteoporosis |
2.9% |
Idiopathic Thrombocytopenic Purpura |
2.8% |
Asthma |
2.7% |
Chronic Hepatitis C |
2.6% |
Behcet's Syndrome |
2.6% |
Insomnia |
2.6% |
Gastritis |
2.1% |
Crohn's Disease |
2.0% |
Acute Lymphocytic Leukaemia |
1.9% |
Diabetes Mellitus |
1.9% |
Constipation |
1.7% |
Multiple Myeloma |
1.6% |
Infection Prophylaxis |
1.5% |
Renal Transplant |
1.4% |
|
White Blood Cell Count Decreased |
14.2% |
Renal Impairment |
7.5% |
Pyrexia |
7.5% |
White Blood Cell Count Increased |
7.0% |
Interstitial Lung Disease |
6.8% |
Rash |
6.2% |
Vomiting |
6.0% |
Pneumonia |
5.9% |
Platelet Count Decreased |
5.6% |
Sepsis |
5.1% |
Liver Disorder |
4.7% |
Pneumocystis Jiroveci Pneumonia |
3.5% |
Hepatic Function Abnormal |
3.3% |
Respiratory Failure |
2.9% |
Thrombocytopenia |
2.9% |
Agranulocytosis |
2.5% |
Toxic Epidermal Necrolysis |
2.3% |
Renal Failure Acute |
2.1% |
Asthma |
2.0% |
Melaena |
2.0% |
|